NCT01189812 - Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Major Depressive DisorderDysthymiaDepression Not Otherwise SpecifiedBorderline Personality Disorder

Interventions

DRUG

Lithium Carbonate

300 mg one time per day for 4 weeks

DRUG

Placebo

Take one time daily for 4 weeks

DRUG

Citalopram

All patients will be administered Citalopram 20 mg to to be taken once daily, by mouth for the duration of the double-blind treatment phase (4 weeks)

Trial Locations (2)

Artemis Institute for Clinical Research, San Diego

Northwest Clinical Research Center, Bellevue